Botox in the womb: a new hope for crippling period pain?
NCT ID NCT06995287
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether injecting botulinum toxin (Botox) into the uterine muscle can reduce severe period pain in women who haven't found relief from standard treatments. 222 women will receive either Botox or a placebo injection via a small camera inserted into the uterus. The main goal is to see if women feel significantly better after 3 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Botulinum toxin (Botox)
What this could lead to
If it works, this could offer a new, long-lasting pain relief option for women with severe period pain who haven't been helped by standard treatments.
What could go wrong
This is still an experimental procedure with risks from the injection itself. The placebo group may also show improvement, and the effect may not last beyond a few months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY DYSMENORRHEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Angers
NOT_YET_RECRUITINGAngers, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Brest
NOT_YET_RECRUITINGBrest, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Lille
NOT_YET_RECRUITINGLille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Nantes
RECRUITINGNantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Rennes
NOT_YET_RECRUITINGRennes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique Brétéché
NOT_YET_RECRUITINGNantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique axium / Centre resilience
NOT_YET_RECRUITINGAix-en-Provence, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital de la Croix-Rousse
NOT_YET_RECRUITINGLyon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••